JP2002529066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002529066A5 JP2002529066A5 JP2000581045A JP2000581045A JP2002529066A5 JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5 JP 2000581045 A JP2000581045 A JP 2000581045A JP 2000581045 A JP2000581045 A JP 2000581045A JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polynucleotide
- ctgf
- guc
- cag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/187,478 US6348329B1 (en) | 1998-11-06 | 1998-11-06 | Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use |
| US09/187,478 | 1998-11-06 | ||
| US09/292,036 US6358741B1 (en) | 1998-11-06 | 1999-04-14 | Connective tissue growth factor (CTGF) and methods of use |
| US09/292,036 | 1999-04-14 | ||
| PCT/US1999/026189 WO2000027868A2 (en) | 1998-11-06 | 1999-11-05 | Connective tissue growth factor (ctgf) and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002529066A JP2002529066A (ja) | 2002-09-10 |
| JP2002529066A5 true JP2002529066A5 (https=) | 2007-01-11 |
| JP4698837B2 JP4698837B2 (ja) | 2011-06-08 |
Family
ID=22689164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000581045A Expired - Lifetime JP4698837B2 (ja) | 1998-11-06 | 1999-11-05 | 結合組織成長因子（ｃｔｇｆ）および使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US6348329B1 (https=) |
| JP (1) | JP4698837B2 (https=) |
| KR (1) | KR20010102943A (https=) |
| HK (1) | HK1039342A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999033878A1 (en) * | 1997-12-25 | 1999-07-08 | Japan Tobacco Inc. | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
| DK1140969T3 (da) * | 1998-12-14 | 2007-09-17 | Univ Miami | Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf |
| US6444657B1 (en) * | 1998-12-31 | 2002-09-03 | Guilford Pharmaceuticals Inc. | Methods for treating certain diseases using naaladase inhibitors |
| US6965025B2 (en) * | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
| EP1925306A3 (en) | 2002-04-30 | 2008-09-17 | Alcon, Inc. | Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure |
| WO2003092584A2 (en) * | 2002-04-30 | 2003-11-13 | Alcon, Inc. | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| WO2003102161A2 (en) * | 2002-06-04 | 2003-12-11 | Metabolex, Inc. | Methods of diagnosing & treating diabetes and insulin resistance |
| US7405274B2 (en) | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
| US20050153395A1 (en) * | 2003-09-29 | 2005-07-14 | Children's Hospital Inc. | Unique integrin binding site in connective tissue growth factor (CTGF) |
| WO2005077413A1 (en) * | 2004-02-11 | 2005-08-25 | Fibrogen, Inc. | Ctgf as target for the therapy of diabetic nephropathy |
| TWI386225B (zh) | 2004-12-23 | 2013-02-21 | Alcon Inc | 用於治療眼睛病症的結締組織生長因子（ＣＴＧＦ）ＲＮＡ干擾（ＲＮＡｉ）抑制技術 |
| US20060275797A1 (en) * | 2005-03-21 | 2006-12-07 | Alcon Manufacturing, Ltd. | Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders |
| WO2008027288A2 (en) | 2006-08-30 | 2008-03-06 | The Trustees Of Columbia University In The City Of New York | Treatment for craniosynostosis by growth factor delivery |
| US8946172B2 (en) * | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
| NZ601660A (en) | 2008-08-25 | 2014-05-30 | Excaliard Pharmaceuticals Inc | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
| EP2448971A1 (en) | 2009-07-02 | 2012-05-09 | Fibrogen, Inc. | Methods for treatment of muscular dystrophy |
| US20120244169A1 (en) | 2009-11-06 | 2012-09-27 | Fibrogen, Inc. | Treatment for Radiation-Induced Disorders |
| US20140134181A1 (en) | 2010-11-05 | 2014-05-15 | Kenneth E. Lipson | Treatment Method For Lung Remodeling Diseases |
| KR101697396B1 (ko) | 2011-02-02 | 2017-01-17 | 엑스칼리아드 파마슈티컬즈, 인코포레이티드 | 결합 조직 성장 인자（ctgf）를 표적으로 하는 안티센스 화합물을 사용하여 켈로이드 또는 비후성 흉터를 치료하는 방법 |
| US8802839B2 (en) | 2011-07-15 | 2014-08-12 | Fibrogen, Inc. | Connective tissue growth factor antisense oligonucleotides |
| EP3386544B1 (en) | 2015-12-10 | 2020-11-25 | Fibrogen, Inc. | Methods for treatment of motor neuron diseases |
| US20200369759A1 (en) | 2019-05-23 | 2020-11-26 | Fibrogen, Inc. | Methods of treatment of muscular dystrophies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5094941A (en) | 1987-12-31 | 1992-03-10 | Zymogenetics, Inc. | Monoclonal antibodies to PDGF |
| US5147294A (en) | 1990-10-01 | 1992-09-15 | Trustees Of Boston University | Therapeutic method for reducing chronic pain in a living subject |
| EP0566673A1 (en) | 1990-12-21 | 1993-10-27 | Creative Biomolecules, Inc. | Biosynthetic pdgf antagonists |
| US5770209A (en) | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| US5408040A (en) | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
| US5596090A (en) * | 1992-07-24 | 1997-01-21 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human VCAM-1 RNA |
| US5916756A (en) | 1993-12-14 | 1999-06-29 | University Of South Florida | Assay of connective tissue growth factor for detection of cell proliferative disorders |
| JP4537507B2 (ja) * | 1997-12-25 | 2010-09-01 | アムジェン インコーポレイテッド | 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途 |
| WO1999033878A1 (en) * | 1997-12-25 | 1999-07-08 | Japan Tobacco Inc. | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
-
1998
- 1998-11-06 US US09/187,478 patent/US6348329B1/en not_active Expired - Lifetime
-
1999
- 1999-04-14 US US09/292,036 patent/US6358741B1/en not_active Expired - Lifetime
- 1999-11-05 HK HK02100878.5A patent/HK1039342A1/zh unknown
- 1999-11-05 JP JP2000581045A patent/JP4698837B2/ja not_active Expired - Lifetime
- 1999-11-05 KR KR1020017005703A patent/KR20010102943A/ko not_active Withdrawn
-
2002
- 2002-02-19 US US10/080,173 patent/US20020115156A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002529066A5 (https=) | ||
| JP7658592B2 (ja) | 非組み込みウイルス送達系およびその関連方法 | |
| Rokeach et al. | Molecular cloning of a cDNA encoding the human Sm-D autoantigen. | |
| EP2966170A1 (en) | HBV inactivation | |
| JP2025114562A (ja) | 非組み込みウイルス送達システムおよびその使用の方法 | |
| JP2008525033A5 (https=) | ||
| CA3134944A1 (en) | Engineered mrna sequences and uses thereof | |
| JPH06500012A (ja) | ウィルス（ｈｉｖ）増殖抑制 | |
| JP2001503277A (ja) | ウイルス変種およびその検出方法 | |
| JP2008533988A5 (https=) | ||
| Taylor | Hepatitis delta virus | |
| JP2021518159A5 (https=) | ||
| US6338949B1 (en) | Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof | |
| CN109929865A (zh) | 基于gal4-uas系统的crispr辅助反式增强子激活基因表达的方法及其应用 | |
| CA2202519A1 (en) | Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase | |
| JP7754829B2 (ja) | インビトロトランスクリプトｍｒｎａ及びこれを含有する薬学組成物 | |
| WO2025045078A1 (zh) | 一种用于调控rna甲基化修饰的编辑系统及其应用 | |
| US20070111231A1 (en) | Detection of mutations in a gene associated with resistance to viral infection, OAS2 and OAS3 | |
| JP2003512028A5 (https=) | ||
| JP2021534109A (ja) | ヘパピティスｂウイルス複製およびヘパピティスｂウイルス表面抗原分泌の抑制方法 | |
| WO2022217072A1 (en) | Rapid drug-screening platform using crispr gain-of-function approach and pseudoviral selection assay to identify clinical biomarker and anti-viral drug targets | |
| JPH09507062A (ja) | 抗ｂ型肝炎ウイルスオリゴヌクレオチド | |
| JPWO2022204093A5 (https=) | ||
| US20230265426A1 (en) | Combinatorial inhibition of mirnas for treatment of heart failure | |
| JPH07303485A (ja) | Ｈｃｖアンチセンスｒｎａ、それを含む発現ベクター、及び該ｒｎａ又は発現ベクターを含むｈｃｖ関連疾患治療剤 |